United Kingdom

People: Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

24 May 2019
Change (% chg)

$-0.37 (-1.90%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chan, Gerald 

Dr. Gerald Chan Ph.D. serves as Chairman of the Board Independent of the company. Chan is a venture capitalist whose work focuses on start-up biotechnology companies founded on novel science. He sits on the boards of several biotech companies including Aduro, Synchroneuron, Matrivax and Stealth Peptides. After completing his doctoral and post-doctoral training at Harvard University, he co-founded the Morningside Group, an investment firm with venture, private equity and property investments that maintains a strong commitment to social responsibility. Gerald is a director of the Morningside Foundation whose donations lead to the founding of the Morningside College of the Chinese University of Hong Kong and to the naming of the Harvard School of Public Health after his late father, T.H. Chan. Gerald remains closely associated with the School of Public Health where he is a Distinguished Visiting Fellow and a member of the Board of Dean’s Advisors. Gerald holds an honorary fellowship at Wolfson College of Oxford University and an honorary Doctor of Social Science degree from the Chinese University of Hong Kong.

Basic Compensation

Total Annual Compensation, USD 10,514
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 810,595
Fiscal Year Total, USD 821,109

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --